ITKP supports TEVA Automation in the commissioning and qualification of biotechnological analogues within the framework of the construction of a new plant for the production of pharmaceuticals

A new plant for the biotechnological production of pharmaceuticals is being built in Ulm south of Germany. Pharmaceutical company Teva is investing 438 million euros in the site for this purpose The "Genesis" project at the group's German headquarters comprises an eight-story office wing and an...

0
0